Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 4Pancreatic Neoplasms 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Colorectal Neoplasms 2Clinical Stage I Gastric Cancer AJCC v8 2Anus Neoplasms 2Tongue Neoplasms 1Sinonasal undifferentiated carcinoma 1Salivary Gland Neoplasms 1Paranasal Sinus Neoplasms 1Pancreatic Adenocarcinoma 1PRETEXT I Hepatoblastoma 1Oropharyngeal Neoplasms 1Neoplasms 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Lymphoid Interstitial Pneumonia 1Laryngeal Neoplasms 1Klatskin Tumor 1Keratosis, Actinic 1Hypopharyngeal Neoplasms 1Hepatoblastoma 1HIV Infections 1Gallbladder Neoplasms 1Fibrolamellar hepatocellular carcinoma 1Epstein-Barr Virus Infections 1DNA Repair-Deficiency Disorders 1Colorectal Neoplasms, Hereditary Nonpolyposis 1

Interventions

X-Rays 5Specimen Handling 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 5Magnetic Resonance Spectroscopy 5Biopsy 4ulixertinib 2tipifarnib 2selpercatinib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Vincristine 2Sorafenib 2Oxaliplatin 2Irinotecan 2Gemcitabine 2Fluorouracil 2Etoposide 2Doxorubicin 2Cisplatin 2Carboplatin 2tazemetostat 1pembrolizumab 1palbociclib 1olaparib 1dostarlimab 1dehydroftorafur 1cabozantinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Hepatoblastoma × dehydroftorafur × Clear all
NCT03533582 2025-12-22

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

Children's Oncology Group

Phase 3 Active not recruiting
537 enrolled
Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡